DDI-DrugBank.d769.s0 >> Coumarin-Derivative Anticoagulants: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving ZOLINZA concomitantly with coumarin-derivative anticoagulants. >> 0-33,151-157,178-211
DDI-DrugBank.d769.s1 >> Physicians should carefully monitor PT and INR in patients concurrently administered ZOLINZA and coumarin derivatives. >> 85-91,97-116
DDI-DrugBank.d769.s2 >> Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other HDAC inhibitors (e.g., valproic acid). >> 6-20,119-125,137-151,160-172
DDI-DrugBank.d769.s3 >> Monitor platelet count every 2 weeks for the first 2 months.
